EU/LA Pearl Index Study - Transdermal Contraceptive Patch
Multicenter, Open-label, Uncontrolled Study to Investigate the Efficacy and Safety of the Transdermal Contraceptive Patch Containing 0.55 mg Ethinyl Estradiol and 2.1 mg Gestodene (Material no. 80876395) in a 21-day Regimen for 13 Cycles in 1650 Healthy Female Subjects
3 other identifiers
interventional
1,694
8 countries
66
Brief Summary
The aim of the present study is to prove efficacy and safety of a new contraceptive patch.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Apr 2009
66 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2009
CompletedFirst Submitted
Initial submission to the registry
May 5, 2009
CompletedFirst Posted
Study publicly available on registry
June 5, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedDecember 5, 2014
December 1, 2014
2.4 years
May 5, 2009
December 4, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurrence of pregnancy
13 treatment cycles each consisting of 28 days and follow-up period of 14 days
Secondary Outcomes (3)
Cervical smear
13 treatment cycles each consisting of 28 days
Adverse events
13 treatment cycles each consisting of 28 days
Bleeding pattern and cycle control
13 treatment cycles each consisting of 28 days
Other Outcomes (2)
Treatment compliance
13 treatment cycles each consisting of 28 days
Subjective assessment of satisfaction with the treatment
13 treatment cycles each consisting of 28 days
Study Arms (1)
Arm 1
EXPERIMENTALInterventions
7-day patch containing 0.55 mg ethinylestradiol (EE) and 2.1 mg gestodene (GSD) in a 21-day regimen
Eligibility Criteria
You may qualify if:
- Requiring contraception
- Normal cervical smear
- Smokers not older than 30 years
- History of regular cyclic menstrual periods
You may not qualify if:
- Pregnancy or lactation
- Obesity (BMI\> 30 kg/m2
- Significant skin reaction to transdermal preparations or sensitivity to surgical / medical tape
- Any disease that may worsen under hormonal treatment (cardiovascular, liver, metabolic)
- Use of other contraceptive methods than study medication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bayerlead
Study Sites (66)
Unknown Facility
Lanús Oeste, Buenos Aires, 1824, Argentina
Unknown Facility
San Isidro, Buenos Aires, B1642CLN, Argentina
Unknown Facility
Buenos Aires, Ciudad Auton. de Buenos Aires, C1280AEB, Argentina
Unknown Facility
Buenos Aires, Ciudad Auton. de Buenos Aires, C1425ASQ, Argentina
Unknown Facility
Buenos Aires, Ciudad Auton. de Buenos Aires, C1425AWC, Argentina
Unknown Facility
Rosario, Santa Fe Province, 2000, Argentina
Unknown Facility
Ashfield, New South Wales, 2031, Australia
Unknown Facility
Adelaide, South Australia, 5000, Australia
Unknown Facility
North Adelaide, South Australia, 5006, Australia
Unknown Facility
Clayton, Victoria, 3168, Australia
Unknown Facility
Nedlands, Western Australia, 6009, Australia
Unknown Facility
Temuco, Región de la Araucanía, 4791348, Chile
Unknown Facility
Santiago, Santiago Metropolitan, 7510025, Chile
Unknown Facility
Santiago, Santiago Metropolitan, 8350488, Chile
Unknown Facility
Santiago, 8320165, Chile
Unknown Facility
Temuco, 4790711, Chile
Unknown Facility
Biarritz, 64200, France
Unknown Facility
Montargis, 45200, France
Unknown Facility
Nîmes, 30029, France
Unknown Facility
Quetigny, 21800, France
Unknown Facility
Reims, 51092, France
Unknown Facility
Saint-Germain-en-Laye, 78100, France
Unknown Facility
Toulouse, 31000, France
Unknown Facility
Frankfurt am Main, Hesse, 60590, Germany
Unknown Facility
Aachen, North Rhine-Westphalia, 52072, Germany
Unknown Facility
Cologne, North Rhine-Westphalia, 50924, Germany
Unknown Facility
Siegen, North Rhine-Westphalia, 57072, Germany
Unknown Facility
Wuppertal, North Rhine-Westphalia, 42103, Germany
Unknown Facility
Dippoldiswalde, Saxony, 01744, Germany
Unknown Facility
Dresden, Saxony, 01099, Germany
Unknown Facility
Leipzig, Saxony, 04207, Germany
Unknown Facility
Leipzig, Saxony, 04299, Germany
Unknown Facility
Blankenburg, Saxony-Anhalt, 38889, Germany
Unknown Facility
Jessen, Saxony-Anhalt, 06917, Germany
Unknown Facility
Magdeburg, Saxony-Anhalt, 39104, Germany
Unknown Facility
Berlin, State of Berlin, 10247, Germany
Unknown Facility
Berlin, State of Berlin, 12587, Germany
Unknown Facility
Berlin, State of Berlin, 13507, Germany
Unknown Facility
Gera, Thuringia, 07545, Germany
Unknown Facility
Francavilla Fontana, Brindisi, 72021, Italy
Unknown Facility
Bologna, 40138, Italy
Unknown Facility
Cagliari, 09124, Italy
Unknown Facility
Catanzaro, 88100, Italy
Unknown Facility
Florence, 50134, Italy
Unknown Facility
Modena, 41124, Italy
Unknown Facility
Palermo, 90127, Italy
Unknown Facility
Pavia, 27100, Italy
Unknown Facility
Perugia, 06156, Italy
Unknown Facility
Pisa, 56126, Italy
Unknown Facility
Siena, 53100, Italy
Unknown Facility
Chihuahua City, Chihuahua, 31350, Mexico
Unknown Facility
Torreón, Coahuila, 27000, Mexico
Unknown Facility
San Luis Potosí City, San Luis Potosí, 78230, Mexico
Unknown Facility
Mexico City, 11000, Mexico
Unknown Facility
México D.F., 10700, Mexico
Unknown Facility
México, D.F., 11000, Mexico
Unknown Facility
Barcelona, Barcelona, 08013, Spain
Unknown Facility
Barcelona, Barcelona, 08028, Spain
Unknown Facility
San Fernando, Cádiz, 11100, Spain
Unknown Facility
Lugo, Lugo, 27002, Spain
Unknown Facility
Pamplona, Pamplona, 31015, Spain
Unknown Facility
Vigo, Pontevedra, 36209, Spain
Unknown Facility
Dos Hermanas, Sevilla, 41700, Spain
Unknown Facility
Alava, Vitoria, 01004, Spain
Unknown Facility
Zaragoza, Zaragoza, 50001, Spain
Unknown Facility
Barcelona, 08035, Spain
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Bayer Study Director
Bayer
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 5, 2009
First Posted
June 5, 2009
Study Start
April 1, 2009
Primary Completion
September 1, 2011
Study Completion
September 1, 2011
Last Updated
December 5, 2014
Record last verified: 2014-12